Knight Therapeutics, Inc.

Knight Therapeutics, Inc.

11.73
CAD
-0.19
(-1.59%)
0.16EPS
65.28P/E
1.04BMarket Cap
Mar 25Next Earn

Knight Therapeutics, Inc. Documents

Q3 FY2020 · Management discussion and analysis

November 13, 2020 · 38 pages

Read Knight Therapeutics, Inc.'s results firsthand

Preview the first 2 pages of this management discussion and analysis
Create a free account to start reading

Full documents are included with Professional

Q3 FY2020 documents